Palomar: U.S. infringement claims have been deemed valid

August 2009
Medical Device Daily;8/19/2009, Vol. 13 Issue 159, p4
The article reports that the Patent and Trademark Office (PTO) in the U.S. has validated all claims in the re-examination of the patent "Permanent Hair removal Using Optical Pulses," or U.S. Patent No. 5,595.568 that belong to Palomar Medical Technologies. Two companies being sued by Palomar for infringing the patent are Candela and Syneron.


Related Articles

  • Candela makes requests for two patent re-examinations.  // Medical Device Daily;12/10/2008, Vol. 12 Issue 219, p4 

    The article reports on the two requests filed by Candela of Wayland, Massachusetts for re-examination with the U.S. Patent & Trademark Office (PTO). Palomar Medical Technologies is the licensee of the patents, which are the subject of its patent infringement lawsuit filed against Candela on...

  • Palomar's patents for hair removal technology confirmed.  // Medical Device Daily;6/16/2009, Vol. 13 Issue 114, p6 

    The article reports on the confirmation of the validity of several patents from Palomar Medical Technologies by the U.S. Patent and Trademark Office. A total of 56 patent claims were confirmed to be valid after a re-examination of U.S. patent No. 5,735,844 titled Hair Removal Using Optical...

  • ASK THE COMMISH.  // Inventors' Digest;Mar2010, Vol. 26 Issue 3, p10 

    The article provides an answer to a question on the appropriateness of sending the infringe patent to the United States Patent and Trademark Office (USPTO) in the U.S.

  • Tivo's 'Time Warp' Hits Wall. Spangler, Todd // Multichannel News;6/14/2010, Vol. 31 Issue 24, p4 

    The article reports on the invalidation of TiVo Inc.'s "Time Warp" digital video recording (DVR) patent ruled by the U.S. Patent and Trademark Office which is made following a review request by its rival Dish Network Corp. and Echostar.

  • Biotage: Following Biotage's request for re-examination US Patent and Trademark Office has rejected all claims in US patent 7,138,061.  // Biomedical Market Newsletter;5/15/2011, p399 

    The article focuses on the rejection of the U.S. Patent and Trademark Office of all the claims of Scientific Plastic Products Inc. concerning alleged infringement in the U.S. patent 7,138,061 by Biotage Inc. It says that an application for the re-examination of patent claims was filed by Biotage...

  • Ten Years After: What Are the Effects of Business Method Patents in Financial Services? HUNT, ROBERT M. // Business Review (Federal Reserve Bank of Philadelphia);2008 Third Quarter, p21 

    The article discusses the trend of business method patents, with at least 12,000 of these granted by the U.S. Patent and Trademarks Office. According to surveys conducted on manufacturing firms in the 1980s and 1990s, only few industries consider patents as primary means of protecting...

  • USPTO Not to Reexamine Claims of VirnetX's Patent.  // Tele-Service News;Jan2012, Vol. 24 Issue 1, p5 

    The article reports on an order issued by the U.S. Patent and Trademark Office (USPTO) denying the request for inter partes reexamination of the U.S. VirnetX Holding Corporation's U.S. Patent No. 7,188,180. The request was filed by Cisco Systems, Inc. on October 25, 2011. It is noted that USPTO...

  • Stopping the Patent Shakedown. Stetter, Aaron // Independent Banker;Jun2014, Vol. 64 Issue 6, p85 

    The article focuses on efforts being made by the Independent Community Bankers of America (ICBA) to community banks from abusive patent-infringement claims. Topics discussed include development of the U.S. Patent and Trademark Office online toolkit, the Leahy-Smith America Invents Act in 2011...

  • Inter partes review has been incredibly successful, so why is the patent office making changes? Lukas, Aaron; Wischhusen, Carl B. // Inside Counsel (SyndiGate Media Inc.);10/5/2015, p1 

    The article offers information on the advantages of inter partes review (IPR) proceedings and impact of new regulations by the U.S. Patent and Trademark Office (USPTO) on the chances of success in pursuing an IPR. Topics discussed include postponing the burdens and costs of litigation, allowing...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics